UK Markets open in 4 hrs 29 mins

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,429.00+10.00 (+0.70%)
At close: 4:39PM BST
Currency in GBp

Valuation measures

Market cap (intra-day) 571.9B
Enterprise value 399.35B
Trailing P/E 13.71
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)2.22
Price/book (mrq)480.98
Enterprise value/revenue 33.06
Enterprise value/EBITDA 710.23

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 31,528.80
52-week low 31,190.80
50-day moving average 31,457.31
200-day moving average 31,387.45

Share statistics

Avg vol (3-month) 36.39M
Avg vol (10-day) 37.01M
Shares outstanding 55.03B
Implied shares outstanding 6N/A
Float 84.89B
% held by insiders 11.18%
% held by institutions 152.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 45.57%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 30.06%
5-year average dividend yield 45.29
Payout ratio 476.78%
Dividend date 3N/A
Ex-dividend date 420 May 2021
Last split factor 22:1
Last split date 328 Oct 1991

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Mar 2021

Profitability

Profit margin 16.21%
Operating margin (ttm)23.63%

Management effectiveness

Return on assets (ttm)5.90%
Return on equity (ttm)29.04%

Income statement

Revenue (ttm)32.43B
Revenue per share (ttm)6.51
Quarterly revenue growth (yoy)-18.40%
Gross profit (ttm)23.21B
EBITDA 9.72B
Net income avi to common (ttm)5.26B
Diluted EPS (ttm)104.20
Quarterly earnings growth (yoy)-31.40%

Balance sheet

Total cash (mrq)4.82B
Total cash per share (mrq)0.96
Total debt (mrq)26.22B
Total debt/equity (mrq)124.79
Current ratio (mrq)0.91
Book value per share (mrq)2.97

Cash flow statement

Operating cash flow (ttm)7.81B
Levered free cash flow (ttm)8.9B